These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24882694)

  • 1. CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: Report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26-29 March 2014.
    Beekman JM; Sermet-Gaudelus I; de Boeck K; Gonska T; Derichs N; Mall MA; Mehta A; Martin U; Drumm M; Amaral MD
    J Cyst Fibros; 2014 Jul; 13(4):363-72. PubMed ID: 24882694
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start.
    Elborn JS
    Thorax; 2012 Jan; 67(1):4-5. PubMed ID: 22058188
    [No Abstract]   [Full Text] [Related]  

  • 3. At the forefront of cystic fibrosis Basic Science research: 16th ECFS Basic Science Conference.
    Taggart CC; Weldon S; Mall MA
    J Cyst Fibros; 2020 Mar; 19(2):169-170. PubMed ID: 32063486
    [No Abstract]   [Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis research topics featured at the 14th ECFS Basic Science Conference: Chairman's summary.
    Mall MA; Hwang TC; Braakman I
    J Cyst Fibros; 2018 Mar; 17(2S):S1-S4. PubMed ID: 29229473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating alternative chloride channels to treat CF: Friends or Foes?: Report on the Meeting of the Basic Science Working Group in Dubrovnik, Croatia.
    Amaral MD; Beekman JM
    J Cyst Fibros; 2020 Jan; 19(1):11-15. PubMed ID: 31676346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
    Birault V; Solari R; Hanrahan J; Thomas DY
    Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis.
    De Boeck K; Zolin A; Cuppens H; Olesen HV; Viviani L
    J Cyst Fibros; 2014 Jul; 13(4):403-9. PubMed ID: 24440181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
    Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
    J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the way to gene therapy in cystic fibrosis].
    Norek A; Bal J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis gene therapy: the first trial.
    Arch Dis Child; 2015 Sep; 100(9):844. PubMed ID: 26205882
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein.
    Schwiebert EM; Benos DJ; Fuller CM
    Am J Med; 1998 Jun; 104(6):576-90. PubMed ID: 9674722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of the non-coding regions of the CFTR gene in cystic fibrosis?
    Castaldo G; Tomaiuolo R
    Expert Rev Respir Med; 2013 Aug; 7(4):327-9. PubMed ID: 23964622
    [No Abstract]   [Full Text] [Related]  

  • 17. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CFTR protein analysis of splice site mutation 2789+5 G-A.
    van Barneveld A; Stanke F; Claass A; Ballmann M; Tümmler B
    J Cyst Fibros; 2008 Mar; 7(2):165-7. PubMed ID: 17707141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the disease liability of CFTR variants.
    Sosnay PR; Castellani C; Corey M; Dorfman R; Zielenski J; Karchin R; Penland CM; Cutting GR
    Methods Mol Biol; 2011; 742():355-72. PubMed ID: 21547743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.